Woolsey Pharmaceuticals
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
233 Broadway Rm 1750, New York City, New...Phone Number
(212) 586-2226Website
www.woolseypharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Woolsey Pharmaceuticals
Woolsey Pharmaceuticals' mission is to help usher in a new era of neurodegenerative disease treatment, saving and improving the lives of patients in need.Explore more
Popular SearchesWoolsey Pharmaceuticals IncWoolsey PharmaceuticalsSIC Code 28,283NAICS Code 32,325Show moreWoolsey Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Woolsey Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Woolsey Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Woolsey Pharmaceuticals
Product Launch: Get notified when Woolsey Pharmaceuticals launches new products
Earning: See what the market has to say on Woolsey Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Woolsey Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Woolsey Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Woolsey Pharmaceuticals had a recent Job posting/layoffs
Woolsey Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Woolsey Pharmaceuticals
Compare insights from companies similar to Woolsey Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Woolsey Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Woolsey Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Woolsey Pharmaceuticals.
Woolsey Pharmaceuticals Tech Stack
A closer look at the technologies used by Woolsey Pharmaceuticals
See more technologies
Woolsey Pharmaceuticals News & Media
Woolsey Pharmaceuticals Completes B Round Extension To Advance Its ALS Program
NEW YORK, Feb. 27, 2025 /PRNewswire/ -- Woolsey Pharmaceuticals today announced the successful completion of an extension to its Series B Preferred financing round by existing investors. "We are immensely grateful for the continued support of our investors and remain steadfast and...Woolsey Pharmaceuticals Secures Additional Key U.S. Patent Claims for BRAVYL® (oral fasudil) in Treating ALS, Including Reducing Neurofilament Light (NfL)
NEW YORK, Jan. 10, 2025 /PRNewswire/ -- Woolsey Pharmaceuticals, whose mission is to usher in a new era of neurodegenerative disease treatment, today announced that the U.S. Patent and Trademark Office (USPTO) has granted additional claims for the use of BRAVYL in treating ALS. This...Woolsey Pharmaceuticals Reveals Breakthrough Findings Showing Spread of Toxic TDP-43 Pathology Greatly Reduced in BRAVYL® (oral fasudil) Treated ALS Patients
NEW YORK, Dec. 9, 2024 /PRNewswire/ -- Woolsey Pharmaceuticals, a clinical-stage pharmaceutical company developing BRAVYL (oral fasudil) for the treatment of Amyotrophic Lateral Sclerosis (ALS), announced that a poster by Dr. Daniel Linseman's laboratory at the University of Denver...Woolsey Pharmaceuticals Announces Several Patents Granted by USPTO, Strengthening the Company's Intellectual Property Position in ALS
NEW YORK, Oct. 21, 2024 /PRNewswire/ -- Woolsey Pharmaceuticals today announced the recent issuance of three key patents that cover cutting-edge innovations related to its drug BRAVYL® (oral fasudil) in the treatment of sporadic Amyotrophic Lateral Sclerosis (ALS) and the development of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Woolsey Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Woolsey Pharmaceuticals' mission is to help usher in a new era of neurodegenerative disease treatment, saving and improving the lives of patients in need.... Read More
